Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD133+ Cell Infusion in Patients With Colorectal Liver Metastases Undergoing Major Liver Resection
2014-001402-18Phase 2Completed
- Sponsor
- ALEJANDRA GARCIA BOTELLA
- Start
- Oct 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous CD133+ peripheral blood stem cells in colorectal cancer (CRC) (2 arms), sponsored by ALEJANDRA GARCIA BOTELLA. Primary endpoint: Liver volumes. Started Oct 2014; status: completed.
02
Drugs
autologous CD133+ peripheral blood stem cells
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2014-001402-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001402-18.